Published in Periodontol 2000 on February 01, 2014
Periodontal Bacteria and Prediabetes Prevalence in ORIGINS: The Oral Infections, Glucose Intolerance, and Insulin Resistance Study. J Dent Res (2015) 1.45
Exploring association between sleep deprivation and chronic periodontitis: A pilot study. J Indian Soc Periodontol (2015) 0.81
Diet-Induced Obesity and Its Differential Impact on Periodontal Bone Loss. J Dent Res (2015) 0.80
Black Tea Extract and Its Theaflavin Derivatives Inhibit the Growth of Periodontopathogens and Modulate Interleukin-8 and β-Defensin Secretion in Oral Epithelial Cells. PLoS One (2015) 0.80
Activation and resolution of periodontal inflammation and its systemic impact. Periodontol 2000 (2015) 0.79
Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum. Sci Rep (2016) 0.78
The Immune Response to Prevotella Bacteria in Chronic Inflammatory Disease. Immunology (2017) 0.77
FOXO1 deletion reduces dendritic cell function and enhances susceptibility to periodontitis. Am J Pathol (2015) 0.77
Total Antioxidant Capacity and Total Oxidant Status in Saliva of Periodontitis Patients in Relation to Bacterial Load. Front Cell Infect Microbiol (2016) 0.77
Gingival Inflammation Associates with Stroke - A Role for Oral Health Personnel in Prevention: A Database Study. PLoS One (2015) 0.76
Community-level assessment of dental plaque bacteria susceptibility to triclosan over 19 years. BMC Oral Health (2014) 0.76
Depression and Inflammatory Periodontal Disease Considerations-An Interdisciplinary Approach. Front Psychol (2016) 0.75
Defining periodontal health. BMC Oral Health (2015) 0.75
Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions? World J Gastroenterol (2016) 0.75
Antimicrobial and Attractant Roles for Chemerin in the Oral Cavity during Inflammatory Gum Disease. Front Immunol (2017) 0.75
Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation. ESC Heart Fail (2017) 0.75
Immuno-pathogenesis of Periodontal Disease: Current and Emerging Paradigms. Curr Oral Health Rep (2014) 0.75
Identification of biomarkers for periodontal disease using the immunoproteomics approach. PeerJ (2016) 0.75
A Systems Biology Approach to Reveal Putative Host-Derived Biomarkers of Periodontitis by Network Topology Characterization of MMP-REDOX/NO and Apoptosis Integrated Pathways. Front Cell Infect Microbiol (2016) 0.75
The Subgingival Microbiome, Systemic Inflammation and Insulin Resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS). J Clin Periodontol (2016) 0.75
Use of ethanol extracts of Terminalia chebula to prevent periodontal disease induced by dental plaque bacteria. BMC Complement Altern Med (2017) 0.75
Periodontal disease and liver cirrhosis: A systematic review. SAGE Open Med (2015) 0.75
Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis. Mediators Inflamm (2017) 0.75
Periodontal-induced chronic inflammation triggers macrophage secretion of Ccl12 to inhibit fibroblast-mediated cardiac wound healing. JCI Insight (2017) 0.75
Antibiotic administration alleviates the aggravating effect of orthodontic force on ligature-induced experimental periodontitis bone loss in mice. J Periodontal Res (2017) 0.75
Reproducibility of a Digital Method to Evaluate Soft Tissue Modifications: A study of Inter and Intra-Operative Measurement Concordance. Open Dent J (2017) 0.75
Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis. PLoS One (2017) 0.75
Nonsurgical periodontal-therapy improves glycosylated hemoglobin levels in pre-diabetic patients with chronic periodontitis. World J Diabetes (2017) 0.75
MicroRNAs and Periodontal Homeostasis. J Dent Res (2017) 0.75
Innate immune recognition. Annu Rev Immunol (2001) 26.65
Toll-like receptors. Annu Rev Immunol (2001) 26.06
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71
The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol (1996) 22.30
Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res (2003) 13.22
Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (1991) 11.04
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 11.02
The lineage decisions of helper T cells. Nat Rev Immunol (2002) 10.61
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Periodontal diseases. Lancet (2005) 10.13
The biology of chemokines and their receptors. Annu Rev Immunol (2000) 9.81
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
The inflammatory reflex. Nature (2002) 9.10
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med (2001) 8.60
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature (1997) 8.59
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Tumor necrosis factor signaling. Cell Death Differ (2003) 8.48
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A (1987) 6.90
Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med (2000) 6.57
Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature (2007) 6.53
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med (2000) 6.06
Proinflammatory cytokines. Chest (2000) 5.89
Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol (2001) 5.87
IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol (1998) 5.79
T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol (2008) 5.78
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
Interleukin-12 and its role in the generation of TH1 cells. Immunol Today (1993) 5.55
Interleukin-10 and related cytokines and receptors. Annu Rev Immunol (2004) 5.41
Resolution of inflammation: state of the art, definitions and terms. FASEB J (2007) 5.12
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol (2003) 5.07
Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol (2001) 4.99
Follicular helper T cells: lineage and location. Immunity (2009) 4.75
Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A (2008) 4.71
Toll-like receptors in the pathogenesis of human disease. Nat Immunol (2004) 4.40
TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol (1998) 4.32
Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol (2005) 4.30
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology (1998) 4.29
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol (2001) 4.23
Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today (1998) 4.21
CCR5 is characteristic of Th1 lymphocytes. Nature (1998) 3.92
Regulatory T cells in the control of host-microorganism interactions (*). Annu Rev Immunol (2009) 3.82
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature (2000) 3.81
Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int (1981) 3.77
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med (2000) 3.71
The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med (1987) 3.61
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol (2002) 3.53
Epithelial cells as sensors for microbial infection. J Clin Invest (1997) 3.47
Activation mechanisms of matrix metalloproteinases. Biol Chem (1997) 3.45
Toll signaling pathways in the innate immune response. Curr Opin Immunol (2000) 3.37
Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol (1993) 3.36
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA (2004) 3.35
Chemokines: multiple levels of leukocyte migration control. Trends Immunol (2004) 3.32
RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol (2001) 3.27
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today (1994) 3.25
Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest (1976) 3.21
Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol (1992) 3.15
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol (1993) 3.14
Primary afferent tachykinins are required to experience moderate to intense pain. Nature (1998) 2.97
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol (1989) 2.86
Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol (1998) 2.84
The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol (2003) 2.83
Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry (1995) 2.75
Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med (2005) 2.72
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev (2004) 2.72
Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev (2002) 2.69
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol (2007) 2.67
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun (1998) 2.66
Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol (2007) 2.66
Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol (2009) 2.65
B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol (2006) 2.56
Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med (2000) 2.54
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest (1993) 2.52
The role of natural killer cells in innate resistance to infection. Curr Opin Immunol (1993) 2.42
Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol (2001) 2.34
Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol (2006) 2.28
Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res (2010) 2.26
Th1 and Th2 subsets: paradigms lost? Immunol Today (1995) 2.21
The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol (2008) 2.21
Toll-like receptors as adjuvant receptors. Biochim Biophys Acta (2002) 2.20
Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med (1998) 2.19
Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res (2003) 2.12
Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol (1996) 2.12
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
Differential regulation of IL-1 production in human monocytes by IFN-gamma and IL-4. J Immunol (1990) 2.06
Bacterial endotoxins. Sci Am (1992) 2.00
Role of matrix metalloproteinases in human periodontal diseases. J Periodontol (1993) 1.98
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96
Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect (2004) 1.94
Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev (2009) 1.93
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 11.02
Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J Periodontol (2009) 3.66
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol (2009) 2.91
Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol (2007) 2.66
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol (2006) 2.37
Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol (2003) 2.23
The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol (2008) 2.21
The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol (2009) 2.20
Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol (2007) 1.98
Deep sequencing of the oral microbiome reveals signatures of periodontal disease. PLoS One (2012) 1.96
Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol (2010) 1.78
Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol (2003) 1.74
Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol (2003) 1.69
Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial. J Periodontol (2004) 1.59
Compliance as a prognostic indicator: retrospective study of 505 patients treated and maintained for 15 years. J Periodontol (2006) 1.58
The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. J Periodontol (2008) 1.55
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem (2009) 1.50
Impact of periodontal therapy on the subgingival microbiota of severe periodontitis: comparison between good responders and individuals with refractory periodontitis using the human oral microbe identification microarray. J Periodontol (2012) 1.47
Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol (2009) 1.38
Hereditary gingival fibromatosis associated with generalized aggressive periodontitis: a case report. J Periodontol (2004) 1.36
Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol (2013) 1.30
Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PLoS One (2011) 1.29
Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol (2013) 1.22
Prevention: Reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol (2010) 1.21
Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol (2008) 1.19
Oral infection, hyperglycemia, and endothelial dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.18
TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol (2009) 1.16
Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun (2003) 1.16
Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 (2003) 1.16
Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 (2013) 1.16
A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol (2004) 1.12
Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils. J Immunol (2010) 1.11
Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol (2010) 1.10
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes. J Leukoc Biol (2006) 1.10
Modeling of trabecular bone and lamina dura following selective alveolar decortication in rats. J Periodontol (2008) 1.09
Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol (2010) 1.09
Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Periodontol 2000 (2007) 1.08
Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol (2012) 1.07
Clinical characteristics and microbiota of progressing slight chronic periodontitis in adults. J Clin Periodontol (2007) 1.05
Hyperactivated B cells in human inflammatory bowel disease. J Leukoc Biol (2009) 1.03
The etiology and pathogenesis of periodontitis revisited. J Appl Oral Sci (2009) 1.03
Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol (2006) 1.02
Lipoxins in chronic inflammation. Crit Rev Oral Biol Med (2003) 1.02
Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun (2003) 1.01
Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J Periodontol (2010) 0.99
Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol (2007) 0.98
Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. Am J Orthod Dentofacial Orthop (2011) 0.98
Epithelial to mesenchymal transition in gingival overgrowth. Am J Pathol (2010) 0.98
Natural resolution of inflammation. Periodontol 2000 (2013) 0.97
Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. J Clin Periodontol (2009) 0.97
B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol (2008) 0.96
Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. J Clin Periodontol (2012) 0.95
Aggressive periodontitis: 5-year follow-up of treatment. J Periodontol (2002) 0.95
Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol (2011) 0.94
The Periodontitis and Vascular Events (PAVE) pilot study: recruitment, retention, and community care controls. J Periodontol (2008) 0.94
PMN responses in chronic periodontal disease: evaluation by gingival crevicular fluid enzymes and elastase-alpha-1-proteinase inhibitor complex. J Clin Periodontol (2002) 0.93
Photobiomodulation accelerates orthodontic alignment in the early phase of treatment. Prog Orthod (2013) 0.93
Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 (2006) 0.93
Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol (2012) 0.92
Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect Immun (2013) 0.92
Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: a randomized, controlled clinical trial. Lasers Med Sci (2012) 0.92
Cardiovascular disease and periodontal diseases: commonality and causation. Compend Contin Educ Dent (2004) 0.91